V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220006501 | 220011435 | null | null | null | null | 2013-05-15 | Nilotinib | N | N | 220030439 | NILOTINIB |
| 220006502 | 220002505 | null | 58.3 | Disease modification (D) | 2014-05-30 | 2014-05-31 | Nilotinib | N | N | 220030443 | NILOTINIB |
| 220006503 | 220002505 | null | 74.5 | Curative (C) | 2013-12-10 | 2013-12-10 | AML 19 TRIAL | 1 | N | 220030443 | AML19 TRIAL |
| 220006504 | 220002505 | 1.57 | 116.6 | Curative (C) | 2014-10-24 | 2014-10-25 | AML 19 TRIAL | Y | N | 220030443 | AML19 TRIAL |
| 220006506 | 220011437 | 1.66 | 107.4 | Curative (C) | 2015-09-03 | 2015-10-24 | AML 19 TRIAL | Y | N | 220030451 | AML19 TRIAL |
| 220006507 | 220002507 | null | 127 | null | 2016-08-10 | 2016-08-10 | AML 19 TRIAL | 1 | N | 220030452 | AML19 TRIAL |
| 220006508 | 220002508 | 1.8 | 63.8 | Curative (C) | 2018-01-17 | 2018-04-20 | AML MyeChild 01 B Cytarabine/Daunoxome + GO | N | N | 220030454 | NOT MATCHED |
| 220006509 | 220002508 | 1.77 | 76 | Disease modification (D) | 2016-02-24 | 2016-02-24 | AML 19 TRIAL | Y | N | 220030454 | AML19 TRIAL |
| 220006510 | 220016154 | null | 54 | Curative (C) | 2015-03-19 | 2015-03-19 | null | N | N | 220030457 | NOT MATCHED |
| 220006511 | 220016154 | 1.75 | 126.7 | Neo-adjuvant (N) | 2016-04-11 | 2016-04-13 | AML 19 TRIAL | 01 | N | 220030457 | AML19 TRIAL |
| 220006512 | 220016154 | 1.88 | null | null | 2015-09-05 | 2016-03-20 | Nilotinib | N | N | 220030457 | NILOTINIB |
| 220006513 | 220016154 | 1.75 | 81 | Curative (C) | 2016-12-30 | 2016-12-30 | AML 19 TRIAL | Y | N | 220030457 | AML19 TRIAL |
| 220006514 | 220002509 | 1.85 | 71.1 | Curative (C) | 2015-07-24 | 2015-07-24 | AML 19 TRIAL | Y | N | 220030463 | AML19 TRIAL |
| 220006515 | 220002509 | 1.68 | 64 | Curative (C) | 2017-06-01 | 2017-06-02 | AML 19 TRIAL | Y | N | 220030463 | AML19 TRIAL |
| 220006518 | 220016155 | 0 | null | Curative (C) | 2013-08-25 | 2013-08-30 | null | N | N | 220030471 | NOT MATCHED |
| 220006519 | 220016155 | null | 111 | Palliative (P) | null | 2014-12-25 | Nilotinib | 02 | N | 220030471 | NILOTINIB |
| 220006520 | 220016155 | 0 | null | null | 2017-10-22 | 2017-10-22 | Nilotinib | N | N | 220030471 | NILOTINIB |
| 220006521 | 220002511 | 1.56 | 0 | Palliative (P) | 2016-06-09 | 2016-06-12 | null | 2 | N | 220030478 | NOT MATCHED |
| 220006522 | 220011441 | null | null | Adjuvant (A) | 2015-07-13 | 2015-07-13 | Nilotinib | N | N | 220030481 | NILOTINIB |
| 220006523 | 220002512 | 0 | 46.2 | Curative (C) | 2013-03-13 | 2013-03-23 | Amsacrine + ANTITHYMOCYTE IMMUNOGLOBULIN (RABBIT) + BUSULFAN + CYTARABINE + FLUDARABINE | 1 | N | 220030482 | NOT MATCHED |
| 220006524 | 220002513 | 0 | null | Curative (C) | 2013-07-28 | 2013-07-28 | Nilotinib | 99 | N | 220030485 | NILOTINIB |
| 220006525 | 220002513 | 1.75 | 0 | Disease modification (D) | 2013-04-12 | 2013-04-12 | Nilotinib | 02 | N | 220030485 | NILOTINIB |
| 220006526 | 220002513 | 1.9 | 0 | Palliative (P) | 2013-10-31 | 2013-10-31 | AML MyeChild 01 IT Cyt | N | N | 220030485 | NOT MATCHED |
| 220006527 | 220018838 | null | null | Curative (C) | 2013-02-20 | 2013-05-27 | null | Y | null | 220030493 | NOT MATCHED |
| 220006528 | 220018838 | 1.74 | 0 | Curative (C) | 2018-01-05 | 2018-01-05 | Nilotinib | N | N | 220030493 | NILOTINIB |
| 220006529 | 220018838 | 1.65 | 68.6 | Curative (C) | 2014-07-22 | 2014-07-22 | AML 19 TRIAL | Y | N | 220030493 | AML19 TRIAL |
| 220006530 | 220021734 | 1.66 | 87.5 | Curative (C) | 2013-11-11 | 2013-11-11 | AML 19 TRIAL | 01 | N | 220030497 | AML19 TRIAL |
| 220006531 | 220002514 | null | null | Disease modification (D) | 2018-04-09 | 2018-04-09 | Nilotinib | N | N | 220030498 | NILOTINIB |
| 220006532 | 220002515 | 1.64 | 68.2 | Curative (C) | 2014-03-22 | 2014-03-22 | AML 19 TRIAL | Y | N | 220030500 | AML19 TRIAL |
| 220006533 | 220011443 | 0 | null | Curative (C) | null | 2016-03-15 | FLAG + Idarubicin | N | null | 220030501 | FLAG + IDARUBICIN |
| 220006534 | 220002516 | 1.77 | null | Curative (C) | 2013-03-23 | 2013-03-29 | Nilotinib | 2 | N | 220030506 | NILOTINIB |
| 220006535 | 220002516 | 1.7 | 69.4 | Curative (C) | 2017-09-16 | 2017-09-16 | AML 19 TRIAL | 1 | N | 220030506 | AML19 TRIAL |
| 220006536 | 220002516 | null | 22.6 | Curative (C) | 2015-04-01 | 2015-04-02 | null | 02 | null | 220030506 | NOT MATCHED |
| 220006537 | 220002517 | 0 | 96.2 | Disease modification (D) | 2014-02-20 | 2014-02-20 | Nilotinib | N | N | 220030509 | NILOTINIB |
| 220006538 | 220002517 | 0 | null | Disease modification (D) | 2015-07-20 | 2015-07-26 | Nilotinib | N | N | 220030509 | NILOTINIB |
| 220006539 | 220002518 | 1.72 | 57.6 | Curative (C) | null | 2016-01-07 | AML 19 TRIAL | Y | N | 220030513 | AML19 TRIAL |
| 220006540 | 220002518 | 1.67 | 75 | null | 2015-01-15 | 2015-01-15 | FLAG + Idarubicin | 02 | N | 220030513 | FLAG + IDARUBICIN |
| 220006541 | 220002519 | 1.94 | 77.5 | null | 2015-06-29 | 2015-06-29 | FLAG + Idarubicin | N | N | 220030516 | FLAG + IDARUBICIN |
| 220006542 | 220002519 | 1.8 | 63.9 | Curative (C) | 2016-10-04 | 2016-10-06 | AML 19 TRIAL | 1 | N | 220030516 | AML19 TRIAL |
| 220006543 | 220002520 | 1.73 | 77.5 | Disease modification (D) | 2013-05-01 | 2013-05-05 | FLAG + Idarubicin | 02 | N | 220030520 | FLAG + IDARUBICIN |
| 220006544 | 220002520 | null | 84.9 | Palliative (P) | 2016-08-02 | 2016-08-02 | Nilotinib | 02 | N | 220030520 | NILOTINIB |
| 220006545 | 220002521 | 1.93 | 76.4 | Curative (C) | 2014-09-30 | 2014-09-30 | AML 19 TRIAL | 1 | N | 220030523 | AML19 TRIAL |
| 220006546 | 220002522 | 1.81 | 21 | Curative (C) | 2013-02-20 | 2013-02-20 | CML Dasatinib | N | N | 220030524 | NOT MATCHED |
| 220006547 | 220002522 | 0 | null | Disease modification (D) | 2015-07-15 | 2015-07-15 | Nilotinib | 99 | N | 220030524 | NILOTINIB |
| 220006548 | 220002523 | 1.52 | 17 | Curative (C) | null | 2015-03-03 | AML Interim Guidelines FLA -Ida | N | N | 220030529 | NOT MATCHED |
| 220006549 | 220011450 | null | 0 | Curative (C) | 2014-09-18 | 2014-09-18 | Nilotinib | N | N | 220030530 | NILOTINIB |
| 220006550 | 220002524 | 1.71 | 61 | Curative (C) | 2017-06-04 | 2017-06-04 | AML 19 TRIAL | N | N | 220030531 | AML19 TRIAL |
| 220006551 | 220002524 | 1.75 | 75 | Curative (C) | 2015-09-28 | 2015-10-17 | FLAG + Idarubicin | N | N | 220030531 | FLAG + IDARUBICIN |
| 220006552 | 220002524 | 1.76 | 55.9 | Curative (C) | null | 2016-09-29 | FLAG + Idarubicin | 02 | N | 220030531 | FLAG + IDARUBICIN |
| 220006553 | 220002524 | 1.85 | 95.8 | Curative (C) | null | 2017-10-02 | AML 19 TRIAL | 01 | N | 220030531 | AML19 TRIAL |